NYSE Nasdaq 100 Earnings Tech U.S. Science SEC Politics AI Business Energy Dow Jones Wall Street Dividend Investing Markets Crude Oil China Economy Wealth S&P 500 Bitcoin (BTC) World NVIDIA (NVDA) Real Estate Fed Health Tesla (TSLA) Software 3M (MMM) Insurance Gold Money Natural Gas Inflation Canada Entertainment Apple (AAPL) U.K. Options Pharmaceuticals Amazon (AMZN) Boeing (BA) Security Construction Retail Donald Trump Meta Platforms (META) Europe Current Microsoft (MSFT) Retirement JPMorgan (JPM) Jim Cramer Hedge Funds Mining Taxes Manufacturing Google Goldman Sachs (GS) Wells Fargo&Co (WFC) Truist Financial Corp (TFC) Elon Musk Netflix (NFLX) Finance Sports Aerospace Tax Bank of America (BAC) Morgan Stanley (MS) Cars Silver York New York Enterprise Japan Live REITs Airlines Israel Interest Rates Kamala Harris Internet Costco (COST) Economics Space Mortgage Property Milton Florida Texas Warren Buffett IPOs War Boston Compound (COMP) Intel (INTC) BlackRock (BLK) AMD (AMD) ASML (ASML)More +
Stock Market News
  • Stocks
  • ETFs
  • Bonds
  • Commodities
  • Earnings
  • Dividends
  • REITs
  • IPOs
  • Cryptocurrency
  • Forex
  • Tech
  • Politics
  • +

2 hours 2025 will be ‘fairly challenging’ for Moderna: AnalystYouTube

2025 will be ‘fairly challenging’ for Moderna: Analyst.

Moderna (MRNA)

X       

2 hours Moderna’s stock pops after biotech ekes out a surprise profit, and revenue beats by a wide marginMarketWatch X       

5 hours Moderna, Inc. 2024 Q3 – Results – Earnings Call PresentationSeeking Alpha X       

6 hours Moderna posts surprise profit as Covid vaccine sales impress, cost cuts take holdYouTube X       

8 hours Moderna reports surprise profit on higher-than-expected COVID vaccine salesYahoo Finance X       

8 hours Moderna Posts A Surprise Profit As Sales Wallop Views. But Will RSV Be Its Undoing?Investor's Business Daily X       

9 hours These Stocks Are Moving the Most Today: Qualcomm, DJT, Arm, Moderna, SolarEdge, Lyft, Zillow, AppLovin, Wolfspeed, and MoreYahoo Finance X       

2 days How to Buy Moderna (MRNA) StockBenzinga X       

2 days Moderna CEO Bancel steps down as sales chief, Bloomberg News reportsInvesting.com X       

3 days Arcturus Gears Up to Report Q3 Earnings: Here’s What to ExpectZacks X       

7 days Moderna (MRNA) Stock Moves -0.66%: What You Should KnowZacks X       

1 week Moderna (MRNA): Expanding Horizons in Gene Editing and mRNA VaccinesInsider Monkey X       

1 week Is Moderna, Inc. (MRNA) The Worst Performing S&P 500 Stock In 2024?Insider Monkey X       

1 week Moderna (MRNA) Exceeds Market Returns: Some Facts to ConsiderZacks X       

1 week Moderna (NASDAQ:MRNA) Stock Price Up 3.9% – What’s Next?MarketBeat X       

1 week Moderna Stock Price Target Slashed. It’s About Vaccines.Yahoo Finance X       

2 weeks UBS Group Trims Moderna (NASDAQ:MRNA) Target Price to $108.00MarketBeat X       

2 weeks Moderna, Inc. (MRNA): Leading the Way in mRNA Vaccines and Respiratory HealthInsider Monkey X       

2 weeks We Think Moderna Still Has A FutureSeeking Alpha X       

2 weeks Moderna: Assessing The Impact Of GSK’s Patent LawsuitSeeking Alpha X       

2 weeks Why Moderna (MRNA) Dipped More Than Broader Market TodayZacks X       

3 weeks mRNA licensing agreements surge 800% amid GSK lawsuitsYahoo Finance X       

3 weeks Vontobel Holding Ltd. Grows Position in Moderna, Inc. (NASDAQ:MRNA)MarketBeat X       

3 weeks Moderna (NASDAQ:MRNA) Hits New 1-Year Low – Time to Sell?MarketBeat X       

3 weeks Investors Purchase High Volume of Put Options on Moderna (NASDAQ:MRNA)MarketBeat X       

3 weeks Moderna (NASDAQ:MRNA) Coverage Initiated by Analysts at Sanford C. BernsteinMarketBeat X       

3 weeks Q3 2024 EPS Estimates for Moderna, Inc. Decreased by Analyst (NASDAQ:MRNA)MarketBeat X       

3 weeks Moderna, Inc. (NASDAQ:MRNA) Shares Bought by Exchange Traded Concepts LLCMarketBeat X       

3 weeks Moderna, Inc. (MRNA) the Most Promising Biotech Stock According to Hedge Funds?Insider Monkey X       

3 weeks GSK sues Moderna for US patent infringement over COVID, RSV vaccinesInvesting.com X       

3 weeks Moderna (NASDAQ:MRNA) PT Lowered to $55.00MarketBeat X       

3 weeks GlaxoSmithKline sues Moderna for US patent infringement over COVID vaccinesInvesting.com X       

3 weeks Moderna (MRNA) Stock Sinks As Market Gains: Here’s WhyZacks X       

3 weeks Polianta Ltd Takes Position in Moderna, Inc. (NASDAQ:MRNA)MarketBeat X       

4 weeks Douglas Lane & Associates LLC Acquires 70,889 Shares of Moderna, Inc. (NASDAQ:MRNA)MarketBeat X       

4 weeks 2 Biotech Stocks That Are Screaming Buys This MonthThe Motley Fool X       

4 weeks Cwm LLC Sells 24,084 Shares of Moderna, Inc. (NASDAQ:MRNA)MarketBeat X       

4 weeks Moderna, Inc. (NASDAQ:MRNA) Shares Sold by Cadinha & Co. LLCMarketBeat X       

4 weeks Moderna (NASDAQ:MRNA) Reaches New 52-Week Low – Here’s What HappenedMarketBeat X       

4 weeks James M. Mock Sells 715 Shares of Moderna, Inc. (NASDAQ:MRNA) StockMarketBeat X       

4 weeks Moderna (MRNA) Stock Drops Despite Market Gains: Important Facts to NoteZacks X       

4 weeks Moderna, Inc. (NASDAQ:MRNA) CFO James M. Mock Sells 715 SharesMarketBeat X       

1 month Sanctuary Advisors LLC Invests $3.14 Million in Moderna, Inc. (NASDAQ:MRNA)MarketBeat X       

1 month Is Moderna Stock A Sell After The Company Slashed Its R&D Budget?Investor's Business Daily X       

1 month ARCT Stock Up as Updated COVID-19 Jab Betters PFE & BNTX’s ComirnatyZacks X       

1 month MRNA Begins Dosing in Pivotal Study on Norovirus VaccineZacks X       

1 month Moderna (MRNA) Rises Higher Than Market: Key FactsZacks X       

1 month Moderna Inc (NASDAQ:MRNA): Jim Cramer Is DisappointedInsider Monkey X       

More news +
Home | Contact
  • X

© 2024 The Stock Market News